poisar

Stocks · News reference

Tempus AI Expands Data and Sequencing Collaboration with Remix Therapeutics

Fiscal.ai

Tempus AI has announced an expansion of its existing data and sequencing collaboration with Remix Therapeutics.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Tempus AI, Inc. (TEM)

    Filed: 2026-11-18 AccNo: 0001193125-26-466240 Size: 212 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits